EUVIMEDEUVIMED entdecken
Crossref

Fragment-Based Discovery of a Small-Molecule RhoGDI2 Ligand, HR3119, that Inhibits Cancer Cell Migration

Mingqing Liu, Shizhang Wan, Shuangxi Guo, Jiuyang Liu, Wenqian Li iD, Lei Wang, Fudong Li, Jiahai Zhang, Xing Liu, Dan Liu, Xuebiao Yao, Jia Gao und 2 weitere

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.5c00361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2025. Verfasst von Mingqing Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital and School of Life Sciences, Ministry of Education Key Laboratory for Membrane-less Organelles and Cellular Dynamics, H…. Hauptthemen laut MEDLINE: Cell Movement, rho Guanine Nucleotide Dissociation Inhibitor beta, Small Molecule Libraries, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: University of Science and Technology of China, National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Movementrho Guanine Nucleotide Dissociation Inhibitor betaSmall Molecule LibrariesAntineoplastic AgentsHumansLigandsCell Line, TumorDrug DiscoveryCrystallography, X-RayProtein Bindingrac1 GTP-Binding ProteinModels, Molecular

Substanzen

Ligandsrho Guanine Nucleotide Dissociation Inhibitor betaSmall Molecule LibrariesARHGDIB protein, humanAntineoplastic Agentsrac1 GTP-Binding Protein

Autor:innen und Institutionen

  • The First Affiliated Hospital and School of Life Sciences, Ministry of Education Key Laboratory for Membrane-less Organelles and Cellular Dynamics, Hefei National Research Center for Interdisciplinary Sciences at the Mi…
  • Department of Pharmacology and Pharmaceutical Sciences, School of Medicine, Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China.

ORCID-Profile: Wenqian Li, Ke Ruan, Wei He

Förderung

  • University of Science and Technology of China
  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province
  • Center for Advanced Interdisciplinary Science and Biomedicine, Institute of Health and Medicine

Zitieren

APA

Liu, M., Wan, S., Guo, S., Liu, J., Li, W., Wang, L., Li, F., Zhang, J., Liu, X., Liu, D., Yao, X., Gao, J., Ruan, K., & He, W. (2025). Fragment-Based Discovery of a Small-Molecule RhoGDI2 Ligand, HR3119, that Inhibits Cancer Cell Migration. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00361

Vancouver

Liu M, Wan S, Guo S, Liu J, Li W, Wang L, et al. Fragment-Based Discovery of a Small-Molecule RhoGDI2 Ligand, HR3119, that Inhibits Cancer Cell Migration. ACS Chemical Biology. 2025. doi:10.1021/acschembio.5c00361

BibTeX
@article{Liu2025,
  author = {Liu, Mingqing and Wan, Shizhang and Guo, Shuangxi and Liu, Jiuyang and Li, Wenqian and Wang, Lei and Li, Fudong and Zhang, Jiahai and Liu, Xing and Liu, Dan and Yao, Xuebiao and Gao, Jia and Ruan, Ke and He, Wei},
  title = {Fragment-Based Discovery of a Small-Molecule RhoGDI2 Ligand, HR3119, that Inhibits Cancer Cell Migration},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.5c00361}
}
Kostenlos starten →